NCT02402036 A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02398526 Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases Status COMPLETED Phase N/A
NCT02396862 Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment Status COMPLETED Phase N/A
NCT02396316 Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Status COMPLETED Phase PHASE3
NCT02395991 Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI Status COMPLETED Phase N/A
NCT02394093 To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults. Status COMPLETED Phase PHASE1
NCT02391116 Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE2
NCT02391064 Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) Status COMPLETED Phase NA
NCT02381964 The Effects of Differing Cognitive Task Demands on Whole-body Energy Metabolism and Cerebral Blood-flow: Modulation by Multivitamins/Minerals and Coenzyme Q10 Status COMPLETED Phase NA
NCT02376127 Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion Status COMPLETED Phase N/A
NCT02368951 Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) Status TERMINATED Phase PHASE1
NCT02367040 Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) Status COMPLETED Phase PHASE3
NCT02367027 Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT02366949 Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel Status COMPLETED Phase PHASE1
NCT02366130 Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer Status COMPLETED Phase PHASE2